Date of Release: November 1, 2013 

Date of Review: November 1, 2015 

Expiration Date: May 31, 2017 

1.   Cystic Fibrosis Carrier Screening    3 hours 
2.   Noninvasive Prenatal Screening (NIPS)   3 hours 
3.   Preimplantation Genetic Diagnosis and Screening   3 hours 
4.   Understanding Your Genome: Genomics in Clinical Practice Symposium     3.45 hours


This series has been approved for AMA PRA Category 1 Credit™            

Overview  

ACMG initiated a series of continuing medical education (CME) opportunities related to the clinical practice of genomic medicine. They focus on the role and use of genome and exome sequencing technologies in clinical practice. Initial offerings include one symposium from which video/audio was captured and three webinars aimed at specific uses of genomic testing. 

The purpose of the series is to educate professionals in the unmet needs area of genomic medicine and advances in next-generation sequencing as it applies to the use of genome sequencing and molecular diagnostics in maternal-fetal health and screening.  The three webinars are on the role of genomics in Cystic Fibrosis Carrier Screening, Noninvasive Prenatal Screening, and Preimplantation Genetic Testing.   The modules for PGD include an overview of predicate forms of prenatal and pre-conceptional screening that has now evolved into genomes; a module on Interpreting Genomic Sequence Variation and PGD specific.

We also have a fourth CME program that is audio/video recorded from a symposium we did about using genomics in clinical practice.  It goes through the basics of patient selection, counseling and consent for genomic sequencing, interpretation of results with analytical and bioinformatics tools and their subsequent clinical interpretation, followed by one on delivering genomic sequencing results. All of these end with a series of case-based vignettes that work to tie together much of what was covered in the more didactic talks.

The webinars and video are freely available for viewing. If you choose to obtain CME/educational credits you will take a posttest and have an 80% passing grade to be eligible for a certificate. A small certificate fee ($30) is required to obtain CME/educational credits for the courses. Please note that NSGC credits are not available at this time. 

The webinars address three areas of genomics clinical practice:

    Cystic Fibrosis Carrier Screening      

    Noninvasive Prenatal Screening (NIPS)     

    Preimplantation Genetic Diagnosis and Screening   

Each webinar contains several modules addressing different aspects of the application of genomic testing to the particular area of clinical use. You may select one module at a time for viewing. If you elect to take the course 
The symposium focused on the evolution of genomic testing from its predicate technologies of targeted genetic testing and includes information on patient selection and test uses, genetic counseling and informed consent, sequencing and bioinformatics in the generation of results, and the reporting and delivery of patient results.  A series of case-based scenarios demonstrate the clinical application of genomics.   

   
    Understanding Your Genome: Genomics in Clinical Practice Symposium   

Target Audience


This series is targeted to educate professionals in the unmet needs of genomic medicine. 

How to obtain CME  

There is CME/educational certificate fee is $30 for each webinar. In order to register for CME credits, please click on the links at the bottom of each webinar page. You are required to complete the entire Self Reporting form and order form to receive your certificate.

Disclaimer: These ACMG educational programs are designed primarily as an educational tool for health care providers who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse, or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or test, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen. 

The ACMG’s Genomics in Clinical Practice is supported by an educational grant from Illumina, Inc. 

1.       Content Validation

Content Validation and Fair Balance 
1. ACMG follows the ACCME policy on Content Validation for CME activities, which requires: 
a) All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. 
b) All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis. 
2. Activities that fall outside the definition of CME/CE; “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients.
3. Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality.  If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.